Search results
Klöckner & Co SE Q2 Earnings Call Highlights
Key Points
- Interested in Klöckner & Co SE? Here are five stocks we like better.
- Q2 EBITDA before special effects reached €63 million, placing Klöckner & Co in the upper half of its €170
QSR to Report Q2 Earnings: Burger King, Tim Hortons in Spotlight
Restaurant Brands International Inc. QSR is scheduled to report second-quarter 2026 results on Aug. 6, before the opening bell.In the previous quarter, the company’s earnings surpassed the Zacks
The Zacks Analyst Blog Highlights SpaceX, Advanced Micro Devices and Booking.com
For Immediate Release
Chicago, IL – August 5, 2026 – Zacks.com announces the list of stocks and ETFs featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest
ETFs in Spotlight as First Solar Shares Jump Post Q2 Earnings Beat
Shares of First Solar Inc. FSLR gained 2.5% on July 31, 2026, following the release of its second-quarter results after the market closed on July 30. The stock continued its upward momentum over
CDW Q2 Earnings & Sales Beat, Soar Y/Y on AI & Infrastructure Spending
CDW Corporation CDW reported second-quarter 2026 non-GAAP earnings per share (EPS) of $2.91, beating the Zacks Consensus Estimate of $2.80. The bottom line increased approximately 12% year over
Lumen Posts Narrower-Than-Expected Q2 Loss, Revenues Drop Y/Y
Lumen Technologies, Inc. LUMN reported a second-quarter 2026 adjusted loss (excluding special items) of 7 cents per share, narrower than the Zacks Consensus Estimate of a loss of 15 cents. The
Is the Options Market Predicting a Spike in Vista Energy Stock?
Investors in Vista Energy, S.A.B. de C.V. VIST need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 21, 2026 $20 Put had some of the highest
Is the Options Market Predicting a Spike in Apple Hospitality Stock?
Investors in Apple Hospitality REIT, Inc. APLE need to pay close attention to the stock based on moves in the options market lately. That is because the October 16, 2026 $22.50 Put had some of the
SYRE's Q2 Loss Narrower Than Expected, Pipeline Progresses
Spyre Therapeutics SYRE incurred a loss of 36 cents per share in the second quarter of 2026, narrower than the Zacks Consensus Estimate of a loss of 71 cents. In the year-ago quarter, the company
Bear of the Day: Boston Scientific (BSX)
Boston Scientific (BSX) manufactures medical devices and products used in various interventional medical specialties worldwide, including cardiovascular and surgical categories.On July 29, BSX
ONON Stock Decision Growth Potential Versus Premium Valuation Now
Investors evaluating On Holding AG ONON must balance a fast-growing premium sportswear business against a valuation that already assumes continued execution. The company is expanding sales, earnings
Can ADTRAN's AI Networking Push Offset Near-Term Execution Risks?
AI infrastructure spending is reshaping the optical networking industry, creating new opportunities for equipment vendors that can deliver higher-capacity connectivity solutions. For ADTRAN
DroneShield Aktie: 125,8 Millionen AUD in H1 2026
DroneShield setzt seine Kurserholung fort. Am heutigen Mittwoch legt die Aktie des australischen Drohnenabwehr-Spezialisten…
Der Beitrag DroneShield Aktie: 125,8 Millionen AUD in H1 2026 erschien
Berkshire Hathaway Enjoys Enduring Conglomerate Advantage
Berkshire Hathaway Inc. BRK.B owns more than 90 subsidiaries, spanning insurance, railroads, utilities, manufacturing, services, retail, and homebuilding. This diversification generates substantial
Will These 3 Insurance Stocks Insure a Q2 Earnings Beat?
As second-quarter 2026 earnings continue to roll in, the insurance sector is emerging as one of the early bright spots. Industry leaders Marsh, AON and Hartford have already cleared the bar
BeOne Medicines Q2 Earnings Call Highlights
Key Points
- Interested in BeOne Medicines Ltd. - Sponsored ADR? Here are five stocks we like better.
- Strong second-quarter performance: BeOne Medicines reported revenue of $1.7 billion, up 30%
Was jetzt für Silber und Platin spricht
LogicBio Therapeutics: ContextLogic Unveils $850M gChem Specialty Chemicals Acquisition
Key Points
- Interested in LogicBio Therapeutics, Inc.? Here are five stocks we like better.
- ContextLogic plans to acquire gChem for $850 million in cash, its second operating-business acquisition
Liupanshui: Wo kühle Sommer zum Lebensgefühl werden
Bureau of Culture, Sports, Broadcast-TV, and Tourism of Liupanshui City, Guizhou Province
LIUPANSHUI, China, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Im Herzen des Wumeng-Gebirges gelegen, bietet die
Cirrus Logic Q1 Earnings Call Highlights
Key Points
- Interested in Cirrus Logic, Inc.? Here are five stocks we like better.
- Record quarterly performance: Cirrus Logic reported fiscal Q1 revenue of $460 million, up 13% year over year





